BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 10746290)

  • 1. [Topical therapy in erectile dysfunction].
    Floth A
    Wien Med Wochenschr; 2000; 150(1-2):14-7. PubMed ID: 10746290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
    Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral terbutaline in the management of pharmacologically induced prolonged erection.
    Priyadarshi S
    Int J Impot Res; 2004 Oct; 16(5):424-6. PubMed ID: 14999218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feline penile erection induced by topical glans penis application of combination alprostadil and SEPA (Topiglan).
    Usta MF; Sanabria J; Bivalacqua TJ; Hellstrom WJ
    Int J Impot Res; 2004 Feb; 16(1):73-7. PubMed ID: 14963475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracavernous injection therapy for male erectile dysfunction.
    Fallon B
    Urol Clin North Am; 1995 Nov; 22(4):833-45. PubMed ID: 7483132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy.
    Nehra A; Blute ML; Barrett DM; Moreland RB
    Int J Impot Res; 2002 Feb; 14 Suppl 1():S38-42. PubMed ID: 11850734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological therapy in erectile dysfunction--current standards and new viewpoint].
    Schultheiss D; Stief CG; Truss MC; Jonas U
    Wien Med Wochenschr; 1997; 147(4-5):102-4. PubMed ID: 9190765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraurethral prostaglandin improves quality of vacuum erection therapy.
    John H; Lehmann K; Hauri D
    Eur Urol; 1996; 29(2):224-6. PubMed ID: 8647152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracorporeal phenylephrine in the treatment of priapism.
    Muruve N; Hosking DH
    J Urol; 1996 Jan; 155(1):141-3. PubMed ID: 7490814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
    Raina R; Lakin MM; Agarwal A; Ausmundson S; Montague DK; Zippe CD
    Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Place of intra-urethral prostaglandin E1 for the treatment of erectile dysfunction].
    Amar E
    Contracept Fertil Sex; 1999; 27(7-8):548-52. PubMed ID: 10495573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostaglandin E1 in the therapy of erectile deficiency.
    Beretta G; Zanollo A; Ascani L; Re B
    Acta Eur Fertil; 1989; 20(5):305-8. PubMed ID: 2636808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intracavernous injections of vasoactive drugs. Contribution to the study of their value in erectile impotence].
    Bondil P; Dorémieux J; Nguyen Qui JL
    J Urol (Paris); 1987; 93(6):361-8. PubMed ID: 3323319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
    Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
    J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUSE therapy: preliminary clinical observations.
    Werthman P; Rajfer J
    Urology; 1997 Nov; 50(5):809-11. PubMed ID: 9372900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
    Fu Q; Yao DH; Jiang YQ
    Asian J Androl; 2000 Dec; 2(4):301-3. PubMed ID: 11202421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection therapy for impotence.
    Kursh ED; Bodner DR; Resnick MI; Althof SE; Turner L; Risen C; Levine SB
    Urol Clin North Am; 1988 Nov; 15(4):625-9. PubMed ID: 3055615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral and topical treatment of erectile dysfunction. Present and future.
    Morales A; Heaton JP; Johnston B; Adams M
    Urol Clin North Am; 1995 Nov; 22(4):879-86. PubMed ID: 7483136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.